ArticleHeliyon2024
Awareness of GMOs in terms of the Iran biosafety act: A case study of Tehran city.
Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Analysis of public perception and socio-demographic drivers of genetically modified organisms in Iran.GM crops & food · 2026Article
- Assessing the adoption and application of the Namibian biosafety labelling regulations and determining their impact on Namibian food and feed importers.Frontiers in bioengineering and biotechnology · 2023Review
- The Importance of Biosecurity in Emerging Biotechnologies and Synthetic Biology.Avicenna journal of medical biotechnologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Given emerging food supply challenges for the world population, Genetic Modified Organisms (GMOs) are referred to as a solution to the upcoming food security crisis. Besides technological advancement, other significant components such as public Awareness play an important role in national and international scientific regulations. Towards this, this study evaluated Tehranian consumers' Awareness (a sample including 946 respondents) about GMOs' risks and benefits, trust in governmental regulation, and the ways to obtain information about GMOs. Specific questionnaires were designed and distributed among participants in four districts in Tehran, and the collected data were used to conduct descriptive and inferential statistics by applying the ANOVA test. The Findings showed that 39 % with a p-value <0.01 of the public is unaware of GMOs in Tehran despite 20 years of commercialization, consumption, and controversial debate about GMOs in media and social networks. Therefore, the goals of public Awareness of science concerning biotechnology have not been met yet. Based on these findings, it can be concluded that public Awareness is not a crucial component in biotechnology advancement, and the other factors, including policymakers' desire, may have more weight.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.